RDEA3170 Tablet and Capsule Bioavailability Study

NCT02448368 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: RDEA3170,10 mg
DRUG: RDEA3170, 2.5 mg
DRUG: RDEA3170, 5 mg
DRUG: RDEA3170, 10 mg
DRUG: RDEA3170, 2.5 mg

Sponsor

Ardea Biosciences, Inc.